Johan Feehally
#151,077
Most Influential Person Now
Johan Feehally's AcademicInfluence.com Rankings
Johan Feehallyphilosophy Degrees
Philosophy
#8356
World Rank
#11715
Historical Rank
Logic
#5389
World Rank
#6783
Historical Rank

Download Badge
Philosophy
Johan Feehally's Degrees
- Doctorate Medicine University of Leicester
Why Is Johan Feehally Influential?
(Suggest an Edit or Addition)Johan Feehally's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis (2012) (1147)
- The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. (2009) (1022)
- The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. (2009) (848)
- International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology (2015) (717)
- Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. (2017) (609)
- Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. (2011) (431)
- Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens (2014) (430)
- Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments (2014) (346)
- Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial (2017) (317)
- Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. (2001) (299)
- Galactosylation of N‐ and O‐linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy (1995) (282)
- Assessment of Global Kidney Health Care Status (2017) (269)
- Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study (2016) (253)
- A comparison of the results of renal transplantation from non-heart-beating, conventional cadaveric, and living donors. (2000) (217)
- HLA has strongest association with IgA nephropathy in genome-wide analysis. (2010) (216)
- Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial (2017) (213)
- A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy. (2017) (199)
- IgA nephropathy: recent developments. (2000) (196)
- Physical Exercise in Patients with Severe Kidney Disease (2010) (179)
- Increased Incidence of End‐stage Renal Failure Secondary to Diabetes Mellitus in Asian Ethnic Groups in the United Kingdom (1992) (178)
- Evaluating a New International Risk-Prediction Tool in IgA Nephropathy. (2019) (174)
- Comprehensive Clinical Nephrology (2000) (173)
- The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. (2010) (171)
- Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study. (2015) (170)
- Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. (1998) (170)
- Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial (2013) (152)
- Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy. (1997) (149)
- High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. (1991) (147)
- An update on the pathogenesis and treatment of IgA nephropathy. (2012) (139)
- Evidence for anti-inflammatory effects of exercise in CKD. (2014) (134)
- Systemic Vasculitis in the 1980s—Is There an Increasing Incidence of Wegener's Graanulomatosis and Microscopic Polyarteritis? (1990) (114)
- The MEST score provides earlier risk prediction in lgA nephropathy. (2016) (113)
- Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. (1999) (112)
- Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA. (1996) (112)
- O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. (2006) (111)
- Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system. (2018) (110)
- Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey (2019) (109)
- Pathogenesis of IgA nephropathy. (1999) (105)
- The MEST score provides earlier risk prediction in IgA nephropathy. (2015) (104)
- O-glycosylation of serum IgD in IgA nephropathy. (2006) (103)
- The mucosa–kidney axis in IgA nephropathy (2016) (100)
- Pathophysiology of cyclosporin A nephrotoxicity: experimental and clinical observations. (1992) (94)
- Treatment of IgA nephropathy. (2006) (93)
- Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy. (1994) (91)
- Sequential study of the IgA system in relapsing IgA nephropathy. (1986) (91)
- Early measurement of interstitial fibrosis predicts long‐term renal function and graft survival in renal transplantation (1996) (90)
- Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation. (1999) (88)
- New insights into the pathogenesis of IgA nephropathy (2003) (85)
- Treatment of IgA nephropathy and Henoch–Schönlein nephritis (2013) (82)
- Progressive Resistance Exercise Training in CKD: A Feasibility Study. (2015) (81)
- Glomerular disease as a cause of isolated microscopic haematuria. (1994) (81)
- Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project. (2018) (80)
- Effective CKD care in European countries: challenges and opportunities for health policy. (2015) (78)
- Does nifedipine ameliorate cyclosporin A nephrotoxicity? (1987) (78)
- IS CHRONIC RENAL TRANSPLANT REJECTION A NON-IMMUNOLOGICAL PHENOMENON? (1986) (78)
- Benefits of regular walking exercise in advanced pre-dialysis chronic kidney disease. (2012) (77)
- The prevalence of diagnosed systemic lupus erythematosus in whites and Indian Asian immigrants in Leicester city, UK. (1992) (76)
- Immunopathogenesis of IgAN (2007) (76)
- Training nephrologists from developing countries: does it have a positive impact? (2012) (75)
- Correcting impotence in the male dialysis patient: experience with testosterone replacement and vacuum tumescence therapy. (1998) (72)
- High risk acute renal failure. (1986) (72)
- Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy. (1999) (71)
- IgA nephropathy. (2005) (70)
- Immune mechanisms in glomerular IgA deposition. (1988) (66)
- IgA myeloma presenting as Henoch-Schönlein purpura with nephritis. (2000) (64)
- High incidence of minimal change nephrotic syndrome in Asians. (1985) (63)
- Chapter 3: UK ESRD Incident Rates in 2008: national and centre-specific analyses (2010) (63)
- Erythropoietin and sexual dysfunction. (1997) (62)
- Risk HLA-DQA 1 and PLA 2 R 1 Alleles in Idiopathic Membranous Nephropathy (2011) (62)
- Distinguishing C1q nephropathy from lupus nephritis. (2004) (60)
- Chronic kidney disease: Health burden of kidney disease recognized by UN (2012) (60)
- Identification of a novel Fcα receptor expressed by human mesangial cells (2000) (59)
- Increased dimeric IgA‐producing B cells in tonsils in IgA nephropathy determined by in situ hybridization for J chain mRNA (1995) (59)
- Outcome of acute renal failure following surgical repair of ruptured abdominal aortic aneurysms. (2000) (59)
- Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversible (1992) (58)
- High incidence of end-stage renal disease in Indo-Asians in the UK. (1995) (57)
- Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy (2015) (57)
- Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units. (2005) (56)
- Glomerular IgA deposition in liver disease. (1999) (53)
- The pathogenic role of IgA1 O‐linked glycosylation in the pathogenesis of IgA nephropathy (Review Article) (2007) (52)
- T-cell homing receptor expression in IgA nephropathy. (2007) (51)
- Diabetic renal disease: differences between Asian and white patients. (1986) (51)
- Primary IgA nephropathy: new insights into pathogenesis. (2011) (49)
- Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update. (2018) (49)
- Immune complex formation in IgA nephropathy: a case of the 'right' antibodies in the 'wrong' place at the 'wrong' time? (2009) (49)
- Structural features of IgA molecules which contribute to IgA nephropathy. (1999) (48)
- A quantitative study comparing adjustment and acceptance of illness in adults on renal replacement therapy. (1999) (47)
- B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy. (2008) (46)
- Systemic and mucosal IgA responses to systemic antigen challenge in IgA nephropathy. (1993) (46)
- Ethical issues in dialysis therapy (2017) (44)
- "Saving Young Lives" with acute kidney injury: the challenge of acute dialysis in low-resource settings. (2016) (44)
- Long‐ and short‐term outcomes in renal allografts with deceased donors: A large recipient and donor genome‐wide association study (2018) (44)
- Primary tuberculosis of the esophagus. (1984) (44)
- The role of continuous ambulatory peritoneal dialysis in end-stage renal failure due to multiple myeloma. (1990) (42)
- Elevation of IgA in IgA nephropathy is localized in the serum and not saliva and is restricted to the IgA1 subclass. (1993) (41)
- Peritoneal Dialysis to Treat Patients with Acute Kidney Injury—The Saving Young Lives Experience in West Africa: Proceedings of the Saving Young Lives Session at the First International Conference of Dialysis in West Africa, Dakar, Senegal, December 2015 (2017) (41)
- Modulation of cellular immune function by cyclophosphamide in children with minimal-change nephropathy. (1984) (40)
- Effect of recombinant human erythropoietin on erythropoiesis in homozygous sickle-cell anaemia and renal failure. (1992) (39)
- IgA nephropathy and Henoch-Schönlein purpura (1999) (39)
- Influence of nifedipine on interstitial fibrosis in renal transplant allografts treated with cyclosporin A. (1994) (39)
- Ethnicity and renal disease. (2005) (38)
- The DQw7 allele at the HLA-DQB locus is associated with susceptibility to IgA nephropathy in Caucasians. (1991) (37)
- Global overview of health systems oversight and financing for kidney care. (2018) (37)
- β1,4-galactosyltransferase 1 is a novel receptor for IgA in human mesangial cells. (2017) (37)
- Increased immunoglobulin A and immunoglobulin A1 cells in bone marrow trephine biopsy specimens in immunoglobulin A nephropathy. (1994) (37)
- IgA1 glycosylation and the pathogenesis of IgA nephropathy. (2000) (36)
- Patient and Staff Perceptions of Intradialytic Exercise before and after Implementation: A Qualitative Study (2015) (35)
- Global Kidney Health Atlas (GKHA): design and methods. (2017) (34)
- RCPE UK consensus conference statement: Management of acute kidney injury: the role of fluids, e-alerts and biomarkers. (2013) (32)
- The value of urine screening in a young adult population. (2004) (32)
- Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial. (2022) (32)
- IgA nephropathy--a disorder of IgA production? (1997) (32)
- Age-Related Variations in Presentation and Outcome in Wegener's Granulomatosis (1997) (32)
- Accelerated Hypertriglyceridemia in Patients on Continuous Ambulatory Peritoneal Dialysis - A Preventable Abnormality (1981) (32)
- Chapter 4: UK ESRD Prevalent Rates in 2008: national and centre-specific analyses (2010) (30)
- The nucleotide sequence of the IgA1 hinge region in IgA nephropathy. (1998) (30)
- Renal and haemodynamic effects of amlodipine and nifedipine in hypertensive renal transplant recipients. (1998) (30)
- Acute renal failure associated with haematological malignancies: A review of 10 years experience (1991) (30)
- Treatment of ethylene glycol poisoning with peritoneal dialysis. (1982) (30)
- Adrenal dysfunction in patients with renal amyloid. (1990) (30)
- IgA nephropathy at two score and one. (2010) (30)
- Improving global health: measuring the success of capacity building outreach programs: a view from the International Society of Nephrology. (2016) (30)
- Parathyroidectomy in chronic renal failure: comparison of three operative strategies. (1996) (29)
- Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes. (2020) (29)
- UK Renal Registry 11th Annual Report (December 2008): Chapter 4 ESRD prevalent rates in 2007 in the UK: national and centre-specific analyses (2009) (29)
- The effect of nifedipine on renal function in normotensive cyclosporin-A-treated renal allograft recipients. (1990) (29)
- Crossover comparison of intravenous and subcutaneous erythropoietin in haemodialysis patients. (1992) (28)
- The pathogenic role of immunoglobulin A polymers in immunoglobulin A nephropathy. (1993) (28)
- Peritoneal Dialysis, Acute Kidney Injury, and the Saving Young Lives Program (2014) (28)
- Saving Young Lives: provision of acute dialysis in low-resource settings (2015) (28)
- The beneficial effects of oral nifedipine on cyclosporin-treated renal transplant recipients — a randomised prospective study (1996) (28)
- The Genetics of IgA Nephropathy: An Overview from Western Countries (2015) (26)
- Expression of the mucosal γδ T cell receptor V region repertoire in patients with IgA nephropathy (1997) (26)
- Renal effects of amlodipine in normotensive renal transplant recipients. (1999) (26)
- Early detection of chronic kidney disease (2008) (25)
- Rate of decline in renal function in Indo‐Asians and Whites with diabetic nephropathy (1998) (25)
- Predicting prognosis in IgA nephropathy. (2001) (25)
- Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool. (2020) (25)
- Global coverage of health information systems for kidney disease: availability, challenges, and opportunities for development. (2018) (25)
- Renal replacement therapy for refugees with end-stage kidney disease: an international survey of the nephrological community. (2016) (24)
- Effects of acute and chronic hypohydration on kidney health and function. (2015) (24)
- CHAPTER 15 – Introduction to Glomerular Disease: Clinical Presentations (2010) (24)
- Time to move forward (2007) (24)
- Familial membranous nephropathy. (1984) (24)
- Correction of Metabolic Acidosis and the Protein Catabolic Rate in Pd Patients (1994) (23)
- Turnover of human tubular cells exposed to proteins in vivo and in vitro. (2001) (23)
- IgA nephropathy: progress before and since Berger. (2011) (23)
- Kidney care in low- and middle-income countries. (2019) (22)
- Disease variations in Asians in Leicester. (1993) (22)
- Plasma erythropoietin levels and acquired cystic disease of the kidney in patients receiving regular haemodialysis treatment (1991) (22)
- CHAPTER 22 – IgA Nephropathy and Henoch-Schönlein Nephritis (2010) (21)
- Chapter 4 ESRD prevalent rates in 2007 in the UK: national and centre-specific analyses (2007) (21)
- Classi fi cation of IgA nephropathy 2016 — the role of crescentic lesions : an update from the IgA Nephropathy Classi fi cation Working Group (2017) (21)
- INCREASING FREQUENCY OF ADULT IgA NEPHROPATHY IN THE UK? (1987) (21)
- Low antibody affinity restricted to the IgA isotype in IgA nephropathy (1994) (20)
- The new Oxford Clinico-Pathological Classification of IgA nephropathy. (2010) (20)
- Effect of nifedipine on renal haemodynamics in an animal model of cyclosporin A nephrotoxicity. (1990) (19)
- Challenges of access to kidney care for children in low-resource settings (2020) (19)
- Identification of a novel Fcalpha receptor expressed by human mesangial cells. (2000) (19)
- Simultaneous in situ hybridisation of native mRNA and immunoglobulin detection by conventional immunofluorescence in paraffin wax embedded sections. (1992) (19)
- Clinical Experience with Icodextrin in Continuous Ambulatory Peritoneal Dialysis Patients (1994) (19)
- RED-CELL SURFACE CHARGE IN GLOMERULAR DISEASE (1986) (18)
- Recurrent proteinuria in chronic lymphocytic leukemia. (1981) (18)
- Gm allotypes in membranous nephropathy. (1983) (18)
- A case of microscopic polyarteritis associated with antineutrophil cytoplasmic antibodies. (1987) (18)
- Origin and structure of pathogenic IgA in IgA nephropathy. (1997) (18)
- IgA nephropathy: "State of the art": a report from the 15th International Symposium on IgA Nephropathy celebrating the 50th anniversary of its first description. (2019) (18)
- Calcium channel blockers and cyclosporine metabolism. (1989) (18)
- Diabetes and renal failure in Indo-Asians in the UK--a paradigm for the study of disease susceptibility. (1997) (18)
- Dietary protein manipulation in experimental nephrotic syndrome. (1988) (18)
- New insights into the pathogenesis of IgA nephropathy - Pathogenesis of IgA nephropathy (2003) (18)
- Development of a framework for minimum and optimal safety and quality standards for hemodialysis and peritoneal dialysis. (2020) (18)
- Lack of awareness of kidney complications despite familiarity with diabetes: a multi-ethnic qualitative study. (2011) (18)
- Combined walking exercise and alkali therapy in patients with CKD4–5 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expression (2013) (17)
- International IgA nephropathy network clinico-pathological classification of IgA nephropathy. (2007) (17)
- Henoch-Schönlein purpura with immunoglobulin A nephropathy and abnormalities of immunoglobulin A in a Wiskott-Aldrich syndrome carrier. (1997) (17)
- Ethnicity and Renal Replacement Therapy (2010) (16)
- The ISN 0by25 Global Snapshot Study (2016) (16)
- An antibody-mediated bullous skin eruption caused by chronic renal allograft rejection. (1982) (16)
- Expression of the mucosal gamma delta T cell receptor V region repertoire in patients with IgA nephropathy. (1997) (16)
- Renal transplant fibrosis: histomorphometric assessment of early renal transplant biopsies for markers of chronic rejection. (1997) (15)
- Prevalence of Hypertension and Diabetes and Coexistence of Chronic Kidney Disease and Cardiovascular Risk in the Population of the Republic of Moldova (2012) (15)
- IgA glycosylation in IgA nephropathy. (1998) (15)
- Expression of T cell receptor variable region families by bone marrow γδ T cells in patients with IgA nephropathy (2002) (15)
- Current Nephrological Practice in the Investigation of Haematuria: Relationship to Incidence of IgA Nephropathy (1989) (15)
- Comprar Comprehensive Clinical Nephrology, 4th Edition | Richard J. Johnson | 9780323058766 | Mosby (2010) (15)
- Current status of health systems financing and oversight for end-stage kidney disease care: a cross-sectional global survey (2021) (15)
- Does increasing haemoglobin concentration and haematocrit have a pressor effect in dialysis patients? (1989) (14)
- Recognition and management of community-acquired acute kidney injury in low-resource settings in the ISN 0by25 trial: A multi-country feasibility study (2021) (14)
- Executive summary and conclusions from the European Hydration Institute Expert Conference on human hydration, health, and performance. (2015) (14)
- UK Renal Registry 11th Annual Report (December 2008): Chapter 3 ESRD incident rates in 2007 in the UK: national and centre-specific analyses (2009) (14)
- The population-level costs of immunosuppression medications for the treatment of glomerulonephritis are increasing over time due to changing patterns of practice (2018) (14)
- Improved immediate graft function with nifedipine in cyclosporine-treated renal allograft recipients--a randomized prospective study. (1992) (13)
- Asymptomatic microscopical haematuria. (1986) (13)
- Nifedipine improves immediate, and 6- and 12-month graft function in cyclosporin A (CyA) treated renal allograft recipients. (1992) (13)
- IgA Nephropathy, Antineutrophil Cytoplasmic Antibodies and Crescentic Glomerulonephritis in a Patient with the Hermansky-Pudlak Syndrome (2001) (13)
- Listeria Monocytogenes Peritonitis Complicating CAPD (1989) (13)
- Autoantibodies in IgA nephropathy. (1995) (12)
- Response of circulating immune complexes to food challenge in relapsing IgA nephropathy (1987) (12)
- Nephrology in developing countries: the ISN's story (2014) (12)
- Microscopic haematuria Role of renal biopsy is undervalued (1994) (12)
- A call to action on World Kidney Day, 8 March 2007. (2007) (11)
- A comparative study of digoxigenin, 2,4-dinitrophenyl, and alkaline phosphatase as deoxyoligonucleotide labels in non-radioisotopic in situ hybridisation. (1997) (11)
- Elective conversion from cyclosporine to azathioprine: long-term follow-up. (1987) (11)
- An update on the treatment of IgA nephropathy (2017) (11)
- Global capacity for clinical research in nephrology: a survey by the International Society of Nephrology. (2018) (11)
- Ethnicity and renal disease: questions and challenges. (2003) (11)
- Sezary cell lymphoma following cyclosporin immunosuppression for renal transplantation. (1991) (10)
- Gut permeability in IgA nephropathy. (1990) (10)
- Response to mucosal antigen challenge in IgA nephropathy. (1995) (9)
- Increased IgA and decreased IgG production by Epstein-Barr virus transformed B cells in culture in IgA nephropathy. (1994) (9)
- The effect of the thromboxane receptor antagonist GR32191B on cyclosporine-induced nephrotoxicity. (1991) (9)
- Complications of using OKT3 for induction of immunosuppression in recipients of kidneys from nonheart beating donors. (1994) (9)
- Poorer graft survival in ethnic minorities: results from a multi-centre UK study of kidney transplant outcomes. (2011) (9)
- A multi-centre qualitative study exploring the experiences of UK South Asian and White Diabetic Patients referred for renal care (2012) (9)
- Targeted therapies: Is there a role for rituximab in nephrotic syndrome? (2014) (8)
- Recovery of renal function after delayed revascularisation of acute occlusion of the renal artery (1988) (8)
- Isolated microscopic haematuria in the genitourinary clinic: the value of renal biopsy (1997) (8)
- The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics (2021) (8)
- Acute renal failure associated with a labetalol overdose. (1990) (8)
- Expression of T cell receptor variable region families by bone marrow gammadelta T cells in patients with IgA nephropathy. (2002) (8)
- The third World Kidney Day: looking back and thinking forward. (2008) (8)
- Urticaria, arthralgia, and nephropathy without amyloidosis: another variant of the Muckle‐Wells syndrome? (1996) (8)
- Abnormal IgD and IgA1 O-glycosylation in hyperimmunoglobulinaemia D and periodic fever syndrome (2009) (8)
- The third World Kidney Day: looking back and thinking forward (2008) (7)
- Immunosuppression in IgA Nephropathy: Guideline Medicine Versus Personalized Medicine. (2017) (7)
- Availability, coverage, and scope of health information systems for kidney care across world countries and regions. (2020) (7)
- Raising awareness of chronic kidney disease among South Asians and primary care: the ABLE project. (2008) (7)
- The International Society of Nephrology (ISN). Roles & challenges in Africa and other resource-limited communities. (2016) (7)
- Impaired IgG response to tetanus toxoid in human membranous nephropathy: association with HLA-DR3. (1986) (7)
- Epidemiology, baseline characteristics and risk of progression in the first South-Asian prospective longitudinal observational IgA nephropathy cohort (2020) (7)
- Strategies for the management of IgA Nephropathy (1994) (7)
- Does Low-Calcium Dialysate Improve the Nutritional Status of Capd Patients? (1993) (6)
- The kidney in myeloma (1986) (6)
- Glucose polymer for ultrafiltration failure in CAPD (1993) (6)
- Predicting the future in immunoglobulin A nephropathy: a new international risk prediction tool. (2020) (6)
- Disparities in end-stage kidney disease care for children: a global survey. (2020) (6)
- Influence of nifedipine on cyclosporin A nephrotoxicity after unilateral nephrectomy in the spontaneously hypertensive rat. (1991) (6)
- Act now against new NHS competition regulations (2013) (6)
- Visceral Glomerular Epithelial Cell DNA Synthesis in Experimental and Human Membranous Disease (1998) (6)
- Variation in IGHMBP2 is not associated with IgA nephropathy in independent studies of UK Caucasian and Chinese Han patients. (2010) (5)
- A spoonful of sugar helps the proteinuria go down? (2007) (5)
- Towards defining antigens in human membranous nephropathy. (1992) (5)
- Is sialylation of IgA the agent provocateur of IgA nephropathy? (2008) (5)
- Protocol and rationale for the first South Asian 5-year prospective longitudinal observational cohort study and biomarker evaluation investigating the clinical course and risk profile of IgA nephropathy: GRACE IgANI cohort (2018) (5)
- Steroid-resistant nephrotic syndrome with mutations in NPHS2 (podocin): report from a three-generation family (2014) (5)
- Treating IgA Nephropathy – Who, When and How? (2003) (5)
- Recurrent acute renal failure with interstitial nephritis due to D-penicillamine. (1987) (5)
- Predictors of renal function in diabetic and non-diabetic renal disease. (1983) (4)
- In vitro immunoglobulin isotype suppression in immunoglobulin A nephropathy. (1994) (4)
- Evidence-based classification of glomerular pathology. (2014) (4)
- Renal failure due to cholesterol embolisation (1995) (4)
- Renal transplantation: nifedipine for the nonstarters? A prospective randomised study. (1993) (4)
- Is Serum Creatinine a Reliable Index of Impaired Renal Function in Cyclosporin (CYA) Treated Renal Allograft Recipients (1989) (4)
- CHAPTER 16 – Introduction to Glomerular Disease: Histologic Classification and Pathogenesis (2010) (4)
- Nutritional Status of Hemodialysis Patients Receiving Recombinant Human Erythropoietin Therapy (1991) (4)
- Phosphoinositide hydrolysis is not enhanced by ciclosporin. (1991) (4)
- The Effect of Correction of Acidosis on Protein Catabolic Rate (Pcr) in Peritoneal Dialysis (Pd) Patients (1993) (4)
- Diabetic kidney disease: act now or pay later Robert C Atkins and Paul Z Zimmet, for the 2010 International Society of Nephrology and International Federation of Kidney Foundations World Kidney Day Steering Committee* and the International Diabetes Federation (2010) (3)
- Immunoglobulin A nephropathy and Henoch–Schönlein purpura (2010) (3)
- The beneficial effects of oral nifedipine on cyclosporin‐treated renal transplant recipients — a randomised prospective study (1996) (3)
- Adverse effects of OKT3 therapy: increased risk with impaired renal function. (1994) (3)
- Immunoglobulin A nephropathy: fish oils and beyond. (1996) (3)
- Variation in IGHMBP2 is not associated with IgA nephropathy in independent studies of UK Caucasian and Chinese Han patients (vol 25, pg 1547, 2010) (2010) (3)
- Deficiency of IgG subclass antibody response to tetanus toxoid associated with high serum IgA levels in IgA nephropathy. (1993) (3)
- Is progression of IgA nephropathy conditioned by genes regulating atherosclerotic damage? (2009) (3)
- Chapter 27 – The Molecular Basis of IgA Nephropathy (2008) (3)
- The third World Kidney Day: Looking back and thinking forward. (2008) (3)
- The International Society of Nephrology (ISN) and the American Nephrologists of Indian Origin (ANIO) Online Clinical Nephropathology Certificate (CNC) program. (2016) (3)
- Is Indian origin a risk factor in cadaveric renal transplantation? (1992) (3)
- Genome-Wide Analysis Identifies Strong Association Between HLA and IgA Nephropathy (2010) (2)
- The third World Kidney Day: looking back and thinking forward. (2008) (2)
- IgA nephropathy: introduction. (2008) (2)
- TO013PROTEINURIA REDUCTION IN IGA NEPHROPATHY BY NEFECON, A TARGETED‑RELEASE FORMULATION OF BUDESONIDE - RESULTS FROM THE NEFIGAN TRIAL (2017) (2)
- Mutant mice provide new insight into the role of (mis-)glycation in IgA nephropathy and other glomerular diseases. (2007) (2)
- A unique role in global nephrology: The International Society of Nephrology, 2011–2020 (2020) (2)
- Abnormalities of IgA1 production in IgA nephropathy (2002) (2)
- ObituaryJean Berger (1930–2011) (2011) (2)
- Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens. (1996) (2)
- The impact of the OFAC regulations on the work of ISN. (2006) (2)
- The International Society of Nephrology: what does "philanthropic" mean for members? (2009) (2)
- Treatment of severe refractory atopic dermatitis with cyclosporin (1991) (2)
- Clinical nephrology - IgA nephropathy, lupus nephritis, vasculitis (2013) (2)
- Treatment of steroid resistant rejection following renal transplantation: benefits and risks of OKT3 therapy. (1996) (2)
- Contents Vol. 59, 1999 (1999) (2)
- Lesson of the Week: Value of opinion by oral physician in diagnosing Wegener's granulomatosis (1994) (2)
- Three-Year Clinical Outcomes of the First South Asian Prospective Longitudinal Observational IgA Nephropathy Cohort (2021) (2)
- In memoriam: Oliver M. Wrong. (2012) (2)
- Locally Prepared Solutions for Treating AKI in Low-Resource Environments (2018) (2)
- The Third World Kidney Day: looking back and thinking forward. (2008) (2)
- Focal segmental glomerulosclerosis: challenges in definitions, pathogenesis and management (2017) (2)
- CAPD: Successful Use in the Treatment of Nephrology Ascites (1989) (2)
- Should Immunosuppressive Therapy Be Used in Slowly Progressive IgA Nephropathy? (2016) (2)
- Corrections to “A comparison of the results of renal transplantation from non-heat-beating, conventional cadaveric, and living donors. Kidney Int 58:2585–2591, 2000” (2001) (1)
- The Effect of Nifedipine (NIF) on [3H]-Cyclosporin a (CYA) Uptake Into Human Proximal Tubular Cells (PTC) (1990) (1)
- The Third World Kidney Day: looking back and thinking forward (2008) (1)
- Appendix G: Coding: Ethnicity, EDTA Primary Renal Diagnoses, EDTA Causes of Death and Treatment Timeline Modality Codes (2010) (1)
- Appendix E: Additional Data Tables for 2008 new and existing patients (2010) (1)
- Immunoglobulin A nephropathy and IgA vasculitis (HSP) (2020) (1)
- The ISN's Fellowship Program: investing in the global future of nephrology (2006) (1)
- The Changing Face of End Stage Renal Disease in a UK Renal Unit (1989) (1)
- Other Non-Immunomodulatory Agents (2009) (1)
- Thin membrane nephropathy (2010) (1)
- Response to ‘Nomenclature of the Oxford classification of IgA nephropathy: do we need to be careful?’ (2010) (1)
- A call to action on World Kidney Day, 8 March 2007 (Editorial) (2007) (1)
- T Lymphocyte Subpopulations and Lymphocyte Function in Minimal Change Nephropathy (MCN) during Long Term Remission (1983) (1)
- Kidney Disease in Ethnic Minority Populations of the United Kingdom (2005) (1)
- Appendix I: Laboratory Conversion Factors (2010) (1)
- The impact of national chronic kidney disease management guidelines in the United Kingdom on referral patterns for South Asian and european patients with type 2 diabetes mellitus (2013) (1)
- A Nephrologist on Sabbatical Leave in the USA (1994) (1)
- 20 – Immunoglobulin A Nephropathy and Related Disorders (2014) (1)
- Culyer, research governance, and all that (2002) (1)
- Nifedipine improves immediate, and 6‐ and 12‐month graft function in cyclosporin A (CyA) treated renal allograft recipients (1992) (1)
- The third World Kidney Day: Looking back and thinking forward (Editorial) (2008) (1)
- Pathogenesis of IgA nephropathy. (1999) (1)
- Appendix D: Methodology used for Analyses of PCT/ Local Authority Incidence and Prevalence Rates and of Standardised Ratios (2010) (1)
- IgA Nephropathy: Evidence of Abnormal Mucosal Immunity (1994) (1)
- The nephritogenic immune response. (1994) (1)
- Progressive resistance exercise training in Chronic Kidney Disease : A 2 feasibility study (2015) (1)
- The Effect of Cyclosporin a (CYA) on Phosphoinositide (PI) Hydrolysis in Rat Aorta and Resistance Arterioles (1989) (1)
- CAPD: successful use in the treatment of nephrogenic ascites. (1989) (1)
- ERA-EDTA Immunonephrology working group. (2010) (1)
- MAJOR ELEMENTS IN THE PATHOGENESIS OF IgA NEPHROPATHY (1)
- STOPping peanut allergy: the saga of food oral immunotherapy (2014) (1)
- Glomerulonephritis from a chronically infected implanted device (2015) (1)
- Identification of β 1 , 4-galactosyltransferase 1 as a novel receptor for IgA in human mesangial cells (2018) (0)
- Progression & risk factors CKD 1-5 (2) (2011) (0)
- World Kidney Forum IgA Nephropathy: Progress Before and Since Berger (2011) (0)
- Effect Of Acute And Regular Exercise On CD4+ Lymphocyte Activation In Chronic Kidney Disease Patients: 1694 (2009) (0)
- Does Increasing Haemoglobin (Hb) or Haematocrit (Hct) Have a Pressor Effect in Dialysis Patients (1989) (0)
- UK Renal Registry 11th Annual Report (December 2008): Appendix D Methodology used for analyses of PCT incidence and prevalence rates and of standardised ratios (2009) (0)
- Novel territory for neutrophils in the pathogenesis of ANCA-associated vasculitides ∗ (2009) (0)
- Patient and staff perceptions of intradialytic exercise before and after implementation (2015) (0)
- WORLD KIDNEY DAY 2008 A MESSAGE TO THE KIDNEY COMMUNITY OF IRAN (LETTER TOEDITOR) (2008) (0)
- Identification of J-Chain mRNA in Duodenal Lamina Propria in IGA Nephropathy (IgAN) (1991) (0)
- Malnutrition & inflammation in CKD 1-5 (2011) (0)
- Long-and short-term outcomes in renal allografts with deceased donors : A (2018) (0)
- UK Renal Registry 11th Annual Report (December 2008): Appendix E Additional data tables for 2007 new and existing patients (2009) (0)
- 6. IgA nephropathy and Henoch-Schonlein purpura (1999) (0)
- Lab methods, progression & risk factors for CKD - 1 (2009) (0)
- Contents Vol. 111, Suppl 1, 2009 (2009) (0)
- The Third World Kidney Day: looking back and thinking forward. (2008) (0)
- Nifedipine does not inhibit ciclosporin A uptake into human cultured proximal tubular cells. (1991) (0)
- Epidemiology and CKD - 1 (2009) (0)
- Textbook of Nephro-Endocrinology (2009) (0)
- UK Renal Registry 11th Annual Report (December 2008): Appendix J Abbreviations used for the renal centre names in the figures and data tables (2009) (0)
- In memoriam: Donal O'Donoghue, 1956-2021. (2021) (0)
- UK Renal Registry 11th Annual Report (December 2008): Appendix F UK Renal Registry dataset specification (2009) (0)
- SP104IS THERE LONG-TERM VALUE OF PATHOLOGY SCORING IN IGA NEPHROPATHY? A VALIGA UPDATE (2017) (0)
- Does the Rate of Progression of Diabetic Nephropathy Differ between Two Ethnic Groups - Whites and Indo-Asians (1997) (0)
- Lab methods, progression & risk factors for CKD - 2 (2009) (0)
- On behalf of the Working Group of the International IgA Nephropathy Network & Renal Pathology Society (2010) (0)
- Identification of a Novel Foa Receptor Expressed by Human Mesangial Cells (1998) (0)
- UK Renal Registry 11th Annual Report (December 2008): Appendix A The UK Renal Registry statement of purpose (2009) (0)
- UK Renal Registry 11th Annual Report (December 2008): Appendix B Definitions and analysis criteria (2009) (0)
- UK Renal Registry 11th Annual Report (December 2008): Appendix G Coding: Ethnicity; EDTA primary renal diagnoses and EDTA causes of death (2009) (0)
- MO040 RISK FACTORS FOR PROGRESSION IN CHILDREN WITH IgA NEPHROPATHY: DATA FROM A EUROPEAN COHORT (2013) (0)
- Contents Vol. 115, Suppl 1, 2010 (2010) (0)
- Transplantation Renal and haemodynamic e V ects of amlodipine and nifedipine in hypertensive renal transplant recipients (1998) (0)
- Impaired renal function in a rural Ugandan population cohort (cid:446)version (cid:697)(cid:402) referees(cid:403) (cid:696) approved with reservations(cid:401) (cid:696) not approved(cid:447) (2019) (0)
- Landmark Papers in Nephrology (2013) (0)
- Evaluation and management of IgA nephropathy (2012) (0)
- Cardiac dysfunction in chronic uraemia (1992) (0)
- Appendix H: Acronyms and Abbreviations used in the Report (2010) (0)
- DISEASE OF THE MONTH IgA Nephropathy : Recent Developments (2000) (0)
- The third World Kidney Day: looking back and thinking forward. (2008) (0)
- Simultaneous insituhybridisation ofnative mRNA andimmunoglobulin detection by conventional immunofluorescence (1992) (0)
- The third World Kidney Day: looking back and thinking forward (2008) (0)
- SAT-377 BIOMARKER EVALUATION OF THE FIRST SOUTH ASIAN PROSPECTIVE LONGITUDINAL COHORT INVESTIGATING THE CLINICAL COURSE AND RISK PROFILE OF IGA NEPHROPATHY: GRACE IGANI COHORT (2020) (0)
- Diabetes, Cyclosporin Nephrotoxicity, and Serum Creatinine Concentration (1991) (0)
- David N.S. Kerr (1927-2014) (2014) (0)
- COMPARINE ADJUSTMENT AND ADULTS ON RENAL REPLACEMENT THERAPY (1999) (0)
- Abnormalities of IgA1 production in IgA nephropathy (2002) (0)
- Haiti and elsewhere: global disaster nephrology (2010) (0)
- Appendix F: UK Renal Registry Dataset Specification (2010) (0)
- Chapter 16 – IgA Nephropathy and Henoch-Schönlein Purpura (2008) (0)
- A call to action on world kidney day, march 8, 2007. Commentary (2007) (0)
- Amyloid tumour in association with ovarian fibroma (1991) (0)
- UK Renal Registry 11th Annual Report (December 2008): Appendix I Laboratory conversion factors (2009) (0)
- Acute renal failure associated withalabetalol overdose (1990) (0)
- ISN moments—238 young Chinese nephrologists supported to learn from the World Congress of Nephrology 2013 (2014) (0)
- Treatments Options for IgA Nephropathy (2005) (0)
- Epidemiology and CKD - 3 (2009) (0)
- Erratum: Variation in IGHMBP2 is not associated with IgA nephropathy inindependent studies of UK Caucasian and Chinese Han patients (Nephrology Dialysis Transplantation (2010): doi: 10.1093/ndt/gfp661) (2010) (0)
- Paediatric nephrology - A (2013) (0)
- The Effect of an Oral Protein Load on Renal Haemodynamics in Cyclosporin and Azathioprine Renal Allograft Recipients (1989) (0)
- Antony John Wing (2012) (0)
- Dietary Protein Manipulation in Experimental Nephrotic Syndrome (NS) (1987) (0)
- Nephrology around the World: Opportunities for Progress (2013) (0)
- UK Renal Registry 11th Annual Report (December 2008): Appendix H Acronyms and abbreviations used in the Report (2009) (0)
- Japan: crisis and recovery. (2011) (0)
- Steroids and immunoglobulin A nephritis. Authors' reply (2006) (0)
- Who should be an author (1984) (0)
- UK Renal Registry 11th Annual Report (December 2008): Appendix C Renal services described for non-physicians (2009) (0)
- Self-assessment questions: Evaluation and management of IgA nephropathy (2012) (0)
- Management of immunosuppression in renal transplant patients with septicaemia. (1992) (0)
- Appendix J: Renal Centre Names and Abbreviations used in the Figures and Data Tables (2010) (0)
- Disease of the Month IgA Nephropathy (2005) (0)
- Age, CKD and other kidney messages (2014) (0)
- Appendix A: The UK Renal Registry Statement of Purpose (2010) (0)
- Subject Index, Vol. 59, 1991 (1991) (0)
- The Third World Kidney Day: Looking Back and Thinking Forward (2007) (0)
- Response to ‘Steroids and IgA nephritis’ (2006) (0)
- A physician with endocarditis (1995) (0)
- Combined walking exercise and alkali therapy in patients with CKD4–5 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expression (2013) (0)
- Clinical Nephrology: primary and secondary glomerulonephritis (2011) (0)
- Poster Presentations (2013) (0)
- Recovery ofrenal function after delayed revascularisatio n of acuteocclusion oftherenal artery (1988) (0)
- POS-103 Serum and Glomerular Complement Components as Biomarkers in the First South-Asian Prospective Longitudinal Observational IgA Nephropathy cohort (GRACE-IgANI) (2022) (0)
- National health policies and strategies for addressing chronic kidney disease: Data from the International Society of Nephrology Global Kidney Health Atlas (2023) (0)
- IgA Nephropathy in Adults and Children (2009) (0)
- Diabetes and renal disease (2013) (0)
- World Kidney Day 2011: protect your kidneys, save your heart. (2011) (0)
- Speaker Abstracts: Tuesday, 6 February 2007 (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Johan Feehally?
Johan Feehally is affiliated with the following schools: